Insights Into Participating in Studies for Uterine Cancer
Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.
Uterine Cancer
Number of patients who decide to enroll in a uterine cancer clinical research, 3 months|Rate of patients who remain in a uterine cancer clinical trial to trial completion, 12 months
Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.